Platelet lysate coating on scaffolds directly and indirectly enhances cell migration, improving bone and blood vessel formation.
暂无分享,去创建一个
[1] Philippe Bierling,et al. In vivo and in vitro comparison of three different allografts vitalized with human mesenchymal stromal cells. , 2012, Tissue engineering. Part A.
[2] S. Falco. The discovery of placenta growth factor and its biological activity , 2012, Experimental & Molecular Medicine.
[3] C. Liang,et al. Expression of RANKL/OPG during bone remodeling in vivo. , 2011, Biochemical and biophysical research communications.
[4] S. Giannini,et al. Mesenchymal stem cells and platelet lysate in fibrin or collagen scaffold promote non‐cemented hip prosthesis integration , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[5] Rozalia Dimitriou,et al. Bone regeneration: current concepts and future directions , 2011, BMC medicine.
[6] A. Matsumura,et al. Enhanced bone formation using hydroxyapatite ceramic coated with fibroblast growth factor-2. , 2010, Acta biomaterialia.
[7] A. Villa,et al. Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. , 2010, Tissue engineering. Part C, Methods.
[8] Richard O C Oreffo,et al. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. , 2010, Biomaterials.
[9] D. Heymann,et al. Mechanisms of bone repair and regeneration. , 2009, Trends in molecular medicine.
[10] C. Ye,et al. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization. , 2009, Journal of vascular surgery.
[11] S. Meuth,et al. Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro. , 2009, Journal of molecular and cellular cardiology.
[12] A. Reinisch,et al. Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. , 2009, Blood.
[13] Pamela J VandeVord,et al. Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization. , 2009, Biomaterials.
[14] I. Martin,et al. Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue. , 2009, Tissue engineering. Part A.
[15] M. Robiony,et al. Osteogenesis distraction and platelet-rich plasma: combined use in restoration of severe atrophic mandible. Long-term results. , 2008, Clinical oral implants research.
[16] J. Kanczler,et al. Osteogenesis and angiogenesis: the potential for engineering bone. , 2008, European cells & materials.
[17] M. Gawaz,et al. Platelets in regenerative medicine , 2008, Basic Research in Cardiology.
[18] J. Folkman,et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. , 2008, Blood.
[19] U. Albisinni,et al. Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. , 2007, The Journal of bone and joint surgery. American volume.
[20] Tain‐Hsiung Chen,et al. Early experience and results of bone graft enriched with autologous platelet gel for recalcitrant nonunions of lower extremity. , 2007, The Journal of trauma.
[21] M. Introna,et al. Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts , 2007, Bone Marrow Transplantation.
[22] P. Robey,et al. Formation of hematopoietic territories and bone by transplanted human bone marrow stromal cells requires a critical cell density. , 2007, Experimental hematology.
[23] C. Kielty,et al. Vascular endothelial growth factor can signal through platelet-derived growth factor receptors , 2007, The Journal of cell biology.
[24] D. Smrke,et al. Allogeneic Platelet Gel with Autologous Cancellous Bone Graft for the Treatment of a Large Bone Defect , 2007, European Surgical Research.
[25] A. Vloon,et al. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. , 2006, Tissue engineering.
[26] J. Granada,et al. Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix , 2006, Thrombosis and Haemostasis.
[27] T. Rabelink,et al. Fibrin and Activated Platelets Cooperatively Guide Stem Cells to a Vascular Injury and Promote Differentiation Towards an Endothelial Cell Phenotype , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[28] Uwe Mehlhorn,et al. Basic Fibroblast Growth Factor Controls Migration in Human Mesenchymal Stem Cells , 2006, Stem cells.
[29] D. Busch,et al. Platelets secrete stromal cell–derived factor 1α and recruit bone marrow–derived progenitor cells to arterial thrombi in vivo , 2006, The Journal of experimental medicine.
[30] U. Heinzmann,et al. Adherent Platelets Recruit and Induce Differentiation of Murine Embryonic Endothelial Progenitor Cells to Mature Endothelial Cells In Vitro , 2006, Circulation research.
[31] X. Holy,et al. Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell‐based therapy applications , 2005, Journal of cellular physiology.
[32] Michael T Longaker,et al. Angiogenesis Is Required for Successful Bone Induction During Distraction Osteogenesis , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] M. Matsuda,et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. , 2005, Biochemical and biophysical research communications.
[34] I. Martineau,et al. Platelet-rich Plasmas: Growth Factor Content and Roles in Wound Healing , 2005, Journal of dental research.
[35] M. Reynolds,et al. Evaluation of the Adjunctive Benefits of Platelet-Rich Plasma in Subantral Sinus Augmentation , 2005, The Journal of craniofacial surgery.
[36] D. Mooney,et al. Combined Angiogenic and Osteogenic Factor Delivery Enhances Bone Marrow Stromal Cell‐Driven Bone Regeneration , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[37] O. Kilian,et al. Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro. , 2004, European journal of medical research.
[38] R. Schmelzeisen,et al. Tissue-engineered bone for maxillary sinus augmentation. , 2004, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[39] S. T. Dheen,et al. Interactions of Chemokines and Chemokine Receptors Mediate the Migration of Mesenchymal Stem Cells to the Impaired Site in the Brain After Hypoglossal Nerve Injury , 2004, Stem cells.
[40] G. Coen. Leptin and bone metabolism. , 2004, Journal of nephrology.
[41] R. Carano,et al. Angiogenesis and bone repair. , 2003, Drug discovery today.
[42] C. Maiorana,et al. Maxillary sinus augmentation with anorganic bovine bone (Bio-Oss) and autologous platelet-rich plasma: preliminary clinical and histologic evaluations. , 2003, The International journal of periodontics & restorative dentistry.
[43] Jay R Lieberman,et al. The role of growth factors in the repair of bone. Biology and clinical applications. , 2002, The Journal of bone and joint surgery. American volume.
[44] M. Robiony,et al. Osteogenesis distraction and platelet-rich plasma for bone restoration of the severely atrophic mandible: preliminary results. , 2002, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[45] W. Puhl,et al. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. , 2002, Bone.
[46] K. Zinn,et al. Analysis of Ti-6Al-4V implants placed with fibroblast growth factor 1 in rat tibiae. , 2001, The International journal of oral & maxillofacial implants.
[47] S. Rafii,et al. Mobilization of Endothelial and Hematopoietic Stem and Progenitor Cells by Adenovector‐Mediated Elevation of Serum Levels of SDF‐1, VEGF, and Angiopoietin‐1 , 2001, Annals of the New York Academy of Sciences.
[48] M. Reynolds,et al. Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with freeze-dried bone allograft: case series. , 2000, Journal of periodontology.
[49] A. Meunier,et al. Tissue-engineered bone regeneration , 2000, Nature Biotechnology.
[50] A Boyde,et al. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. , 2000, Journal of biomedical materials research.
[51] J. Isner,et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.
[52] G. Neufeld,et al. Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[53] J. Isner,et al. Chemotactic Properties of Angiopoietin-1 and -2, Ligands for the Endothelial-specific Receptor Tyrosine Kinase Tie2* , 1998, The Journal of Biological Chemistry.
[54] V. Goldberg,et al. The Effect of Implants Loaded with Autologous Mesenchymal Stem Cells on the Healing of Canine Segmental Bone Defects* , 1998, The Journal of bone and joint surgery. American volume.
[55] R. Marx,et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. , 1998, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[56] I. Martin,et al. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. , 1997, Endocrinology.
[57] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[58] N. Ferrara,et al. The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.
[59] A. Caplan,et al. Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF‐β1 or PDGF‐BB as assayed in vivo and in vitro , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[60] T A Einhorn,et al. Enhancement of fracture-healing. , 1995, The Journal of bone and joint surgery. American volume.
[61] S. Gronthos,et al. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. , 1995, Blood.
[62] C. Hou,et al. Insulin promotes bone formation in augmented maxillary sinus in diabetic rabbits , 2012 .
[63] Philippe Bierling,et al. Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. , 2010, Biomaterials.
[64] R. Cancedda,et al. The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. , 2010, Biomaterials.
[65] M. Alobera-Gracia,et al. Physiological bases of bone regeneration I. Histology and physiology of bone tissue. , 2006, Medicina oral, patologia oral y cirugia bucal.
[66] W. Schaper,et al. An Engineered Heparin-Binding Form of VEGF-E (hbVEGF-E). Biological effects in vitro and mobilizatiion of precursor cells , 2004, Angiogenesis.
[67] E. Livne,et al. Bone defect repair in rat tibia by TGF-β1 and IGF-1 released from hydrogel scaffold , 2004, Cell and Tissue Banking.
[68] M. Sefton,et al. Tissue engineering. , 1998, Journal of cutaneous medicine and surgery.
[69] B. Weksler,et al. Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[70] J. Vacanti,et al. Tissue engineering : Frontiers in biotechnology , 1993 .